Isabella Atzeni

Dr. Isabella Atzeni is an active researcher focused on systemic sclerosis and related autoimmune conditions. Her work integrates clinical observations, transcriptomics, and innovative imaging techniques to explore disease mechanisms and biomarkers. Collaborations span multidisciplinary teams in pharmacology, immunology, and medical imaging.

Research interests center on advanced glycation end products (AGEs), interstitial lung disease, pulmonary hypertension, and calcinosis cutis in systemic sclerosis patients. She develops non-invasive diagnostic tools like the AGE reader and utilizes PET imaging to track disease progression.

Recent studies highlight the role of chemokines like CXCL10 in interstitial lung disease onset and the predictive value of soluble receptors for pulmonary complications. Her work contributes to UN Sustainable Development Goals by advancing medical diagnostics and patient care in rheumatology.